Market revenue in 2022 | USD 28.6 million |
Market revenue in 2030 | USD 46.7 million |
Growth rate | 6.3% (CAGR from 2022 to 2030) |
Largest segment | Extracorporeal co2 machines |
Fastest growing segment | Other Products |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Extracorporeal CO2 machines, Disposables, Other Products |
Key market players worldwide | Medtronic PLC, Getinge AB ADR, Fresenius Medical Care AG, LivaNova PLC, Aferetica, Estor |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to extracorporeal co2 removal devices market will help companies and investors design strategic landscapes.
Extracorporeal co2 machines was the largest segment with a revenue share of 50.7% in 2022. Horizon Databook has segmented the U.S. extracorporeal co2 removal devices market based on extracorporeal co2 machines, disposables, other products covering the revenue growth of each sub-segment from 2017 to 2030.
The U.S. accounted for the largest share in the North America extracorporeal CO2 removal devices market. The U.S. dominated the overall North American market in terms of revenue share in 2021 with 88.9% share. As per 2011–2015 World Bank Health Expenditure, the U.S. spends nearly 17.1% of its GDP on healthcare.
Increasing prevalence of chronic obstructive pulmonary disease, cardiopulmonary disease, and respiratory failure in this region are some of the key factors that are expected to drive the market over the forecast period. According to the American Lung Association, there were around 11 million people in the U.S. who were diagnosed with COPD, whereas 24 million people were estimated to be left undiagnosed.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. extracorporeal co2 removal devices market, including forecasts for subscribers. This country databook contains high-level insights into U.S. extracorporeal co2 removal devices market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account